Integrated transcriptomic analysis reveals a lncRNA-miRNA-TF-mRNA regulatory network underlying quercetin's anti-hepatocellular carcinoma effects.
2/5 보강
OpenAlex 토픽 ·
Cancer-related molecular mechanisms research
MicroRNA in disease regulation
PI3K/AKT/mTOR signaling in cancer
[BACKGROUND] Quercetin (QUR) exhibits multiple pharmacological activities against hepatocellular carcinoma (HCC).
APA
Tong Lin, Ningna Weng, et al. (2026). Integrated transcriptomic analysis reveals a lncRNA-miRNA-TF-mRNA regulatory network underlying quercetin's anti-hepatocellular carcinoma effects.. Biochemical and biophysical research communications, 817, 153651. https://doi.org/10.1016/j.bbrc.2026.153651
MLA
Tong Lin, et al.. "Integrated transcriptomic analysis reveals a lncRNA-miRNA-TF-mRNA regulatory network underlying quercetin's anti-hepatocellular carcinoma effects.." Biochemical and biophysical research communications, vol. 817, 2026, pp. 153651.
PMID
41962406 ↗
Abstract 한글 요약
[BACKGROUND] Quercetin (QUR) exhibits multiple pharmacological activities against hepatocellular carcinoma (HCC). Competing endogenous RNA (ceRNA) networks and transcription factors (TFs) play critical roles in oncogenesis and cancer progression, however, the integrated ceRNA- and TF-mediated mechanisms of QUR in the treatment of HCC remain unknown.
[METHODS] The anti-proliferative, anti-migratory, and pro-apoptotic effects of QUR on HepG2 cells were evaluated using CCK-8, colony formation, wound-healing, and flow cytometry assays. Transcriptome sequencing was performed to identify differentially expressed (DE) long non-coding RNAs (lncRNAs), micro RNAs (miRNAs), and messenger RNAs (mRNAs) after QUR treatment. Functional enrichment, protein-protein interaction (PPI) analysis, and survival analyses were performed to elucidate therapeutic mechanisms and prognostic biomarkers. A lncRNA-miRNA-TF-mRNA regulatory network was constructed by integrating multiple databases, and its clinical relevance was assessed using TCGA and GTEx data.
[RESULTS] QUR dose-dependently inhibited the proliferation, colony formation, migration, and induced apoptosis of HCC cells. Transcriptomic profiling identified 647 DEmRNAs, 304 DElncRNAs, and 17 DEmiRNAs. Down-regulated DEmRNAs were enriched in nucleosome, chromatin, and telomere metabolism, while up-regulated DEmRNAs were involved in cytokine activity and immune cell differentiation. Key pathways included metabolic reprogramming, cytokine signaling, PI3K/AKT, and viral carcinogenesis. PPI analysis revealed five functional clusters, and survival analysis identified 12 prognosis-associated DEmRNAs (e.g., AURKA, CCNB1, KIF20A, and PLK1). The constructed regulatory network comprised three DEmiRNAs, eight TFs, five DEmRNAs, and 20 DElncRNAs, revealing coordinated miRNA-TF cross-talk and lncRNA-meditated ceRNA axes that fine-tuned key mRNAs. Mechanistically, QUR might balance oncogene and tumor suppressor expression, thereby inhibiting metabolism, mitosis, and transcription in HCC cells, while enhancing anti-cancer immunity and extrinsic apoptosis.
[CONCLUSIONS] This study delineated a comprehensive lncRNA-miRNA-TF-mRNA network that elucidated the systematic mechanisms of QUR against HCC, offering potential biomarkers and therapeutic targets for further investigation.
[METHODS] The anti-proliferative, anti-migratory, and pro-apoptotic effects of QUR on HepG2 cells were evaluated using CCK-8, colony formation, wound-healing, and flow cytometry assays. Transcriptome sequencing was performed to identify differentially expressed (DE) long non-coding RNAs (lncRNAs), micro RNAs (miRNAs), and messenger RNAs (mRNAs) after QUR treatment. Functional enrichment, protein-protein interaction (PPI) analysis, and survival analyses were performed to elucidate therapeutic mechanisms and prognostic biomarkers. A lncRNA-miRNA-TF-mRNA regulatory network was constructed by integrating multiple databases, and its clinical relevance was assessed using TCGA and GTEx data.
[RESULTS] QUR dose-dependently inhibited the proliferation, colony formation, migration, and induced apoptosis of HCC cells. Transcriptomic profiling identified 647 DEmRNAs, 304 DElncRNAs, and 17 DEmiRNAs. Down-regulated DEmRNAs were enriched in nucleosome, chromatin, and telomere metabolism, while up-regulated DEmRNAs were involved in cytokine activity and immune cell differentiation. Key pathways included metabolic reprogramming, cytokine signaling, PI3K/AKT, and viral carcinogenesis. PPI analysis revealed five functional clusters, and survival analysis identified 12 prognosis-associated DEmRNAs (e.g., AURKA, CCNB1, KIF20A, and PLK1). The constructed regulatory network comprised three DEmiRNAs, eight TFs, five DEmRNAs, and 20 DElncRNAs, revealing coordinated miRNA-TF cross-talk and lncRNA-meditated ceRNA axes that fine-tuned key mRNAs. Mechanistically, QUR might balance oncogene and tumor suppressor expression, thereby inhibiting metabolism, mitosis, and transcription in HCC cells, while enhancing anti-cancer immunity and extrinsic apoptosis.
[CONCLUSIONS] This study delineated a comprehensive lncRNA-miRNA-TF-mRNA network that elucidated the systematic mechanisms of QUR against HCC, offering potential biomarkers and therapeutic targets for further investigation.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- RNA
- Long Noncoding
- Carcinoma
- Hepatocellular
- Liver Neoplasms
- Gene Regulatory Networks
- MicroRNAs
- Quercetin
- Messenger
- Gene Expression Regulation
- Neoplastic
- Gene Expression Profiling
- Hep G2 Cells
- Transcription Factors
- Cell Proliferation
- Apoptosis
- Cell Movement
- Transcriptome
- Hepatocellular carcinoma
- ceRNA
- lncRNA
- miRNA
- transcription factor
같은 제1저자의 인용 많은 논문 (2)
- Low-Dose Fractionated Radiation Therapy as a Chemopotentiator of Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma: A Single-Arm Phase 1/2 Trial.
- Fluorinated Proteolysis Targeting Chimeras-Sorafenib Nanoassembly for Epigenetic Remodeling to Combat Multi-Pathway Drug Resistance in Hepatocellular Carcinoma.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.